- Home
- BTDR vs NVAX Comparison
BTDR vs NVAX Comparison
Compare BTDR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTDR
- NVAX
- Stock Information
- Founded
- BTDR 2021
- NVAX 1987
- Country
- BTDR Singapore
- NVAX United States
- Employees
- BTDR N/A
- NVAX N/A
- Industry
- BTDR EDP Services
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTDR Technology
- NVAX Health Care
- Exchange
- BTDR Nasdaq
- NVAX Nasdaq
- Market Cap
- BTDR 3.0B
- NVAX 1.3B
- IPO Year
- BTDR N/A
- NVAX 1995
- Fundamental
- Price
- BTDR $11.40
- NVAX $6.60
- Analyst Decision
- BTDR Strong Buy
- NVAX Buy
- Analyst Count
- BTDR 10
- NVAX 5
- Target Price
- BTDR $19.35
- NVAX $16.60
- AVG Volume (30 Days)
- BTDR 4.7M
- NVAX 5.5M
- Earning Date
- BTDR 08-11-2025
- NVAX 08-07-2025
- Dividend Yield
- BTDR N/A
- NVAX N/A
- EPS Growth
- BTDR N/A
- NVAX N/A
- EPS
- BTDR N/A
- NVAX 2.97
- Revenue
- BTDR $300,404,000.00
- NVAX $1,254,962,000.00
- Revenue This Year
- BTDR $44.04
- NVAX $56.85
- Revenue Next Year
- BTDR $110.60
- NVAX N/A
- P/E Ratio
- BTDR N/A
- NVAX $2.22
- Revenue Growth
- BTDR N/A
- NVAX 25.92
- 52 Week Low
- BTDR $5.40
- NVAX $5.01
- 52 Week High
- BTDR $26.99
- NVAX $17.81
- Technical
- Relative Strength Index (RSI)
- BTDR 40.53
- NVAX 42.34
- Support Level
- BTDR $10.41
- NVAX $6.26
- Resistance Level
- BTDR $11.70
- NVAX $6.60
- Average True Range (ATR)
- BTDR 0.65
- NVAX 0.27
- MACD
- BTDR -0.20
- NVAX -0.06
- Stochastic Oscillator
- BTDR 15.48
- NVAX 15.94
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.